Article
Effectiveness of an Unsupervised Primaquine Regimen for Preventing Plasmodium vivax Malaria Relapses in Northeast Myanmar: A Single-Arm Nonrandomized Observational Study.
The Journal of infectious diseases - 15 May 2024
Malla Pallavi, Wang Zenglei, Brashear Awtum, Yang Zhaoqing, Lo Eugenia, Baird Kevin, Wang Chengqi, Cui Liwang
Abstract excerpt
BACKGROUND: Plasmodium vivax presents a significant challenge for malaria elimination in the Greater Mekong Subregion. We evaluated the effectiveness of primaquine for reducing relapses of vivax malaria. METHODS: Patients with uncomplicated P vivax malaria from eastern Myanmar received chloroquine (25-mg base/kg given in 3 days) plus unsupervised PQ (0.25 mg/kg/d for 14 days) without screening for...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
